Dennis M. Lanfear - Jan 20, 2025 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
President & CEO, Director
Signature
/s/ Bryan McMichael, as Attorney-in-Fact for Dennis M. Lanfear
Stock symbol
CHRS
Transactions as of
Jan 20, 2025
Transactions value $
-$16,416
Form type
4
Date filed
1/22/2025, 07:48 PM
Previous filing
Jan 14, 2025
Next filing
May 9, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability -$16.4K -11.8K -1.69% $1.39 685K Jan 20, 2025 Direct F1
holding CHRS Common Stock 433K Jan 20, 2025 By Trust F2
holding CHRS Common Stock 87K Jan 20, 2025 By LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.
F2 These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
F3 These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.